Summit Partners Public Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-653,445
Closed -$107M 189
2026
Q1
$107M Sell
653,445
-255,635
-28% -$39.3M 2.87% 5
2025
Q4
$158M Sell
909,080
-132,765
-13% -$24.2M 3.29% 3
2025
Q3
$150M Buy
1,041,845
+32,908
+3% +$4.03M 3.11% 3
2025
Q2
$102M Buy
1,008,937
+304,571
+43% +$23.3M 2.57% 7
2025
Q1
$53.7M Buy
704,366
+65,518
+10% +$5.01M 1.38% 21
2024
Q4
$44.1M Buy
638,848
+60,492
+10% +$4.36M 0.84% 45
2024
Q3
$42.2M Buy
578,356
+306,821
+113% +$22.6M 1.31% 29
2024
Q2
$18.2M Buy
+271,535
New +$10.5M 0.7% 50
2024
Q1
Sell
-338,491
Closed -$9.47M 152
2023
Q4
$10.5M Buy
+338,491
New +$8.78M 0.44% 80

Other funds holding INSM

Summit Partners Public Asset Management's INSM Position: Q2 2026 in Review

Summit Partners Public Asset Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 653,445 shares — an estimated $107M sold.

Summit Partners Public Asset Management first reported a position in INSM in Q4 2023 and held it in 9 quarters. The position peaked at $158M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Summit Partners Public Asset Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 653,445 Insmed shares in Q2 2026, an estimated $107M.
  • Summit Partners Public Asset Management first reported a position in Insmed in Q4 2023 and held it in 9 quarters.
  • Summit Partners Public Asset Management's Insmed position peaked at $158M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.